GRNH) announces exclusive multi-million dollar deal with Neurofarms



Anaheim, California – October 5, 2021 (Newsfile Corp.) ( Newswire) GreenGro Technologies, Inc. (OTC Pink: GRNH), an established provider of environmentally friendly green technologies to the industrial hemp and cannabis industries , announced today that it has secured an exclusive multi-million dollar agreement to oversee the manufacture and distribution of premium medical cannabis products and cannabinoid pharmaceutical drugs in the United States and Canada. Mexico. The five-year agreement was awarded to the company by Neurofarrms, a California holistic and wellness company that develops transformative therapies derived from tetrahydrocannabinol (THC) and cannabinoids (CBD) for people with medical conditions with high needs. unmet medical professionals. The Company expects to disclose further details regarding the size of this deal and its expected future financial contributions in a follow-up press release.

“We are proud of the success and continued progress of our cannabinoid drug development program which has reached the highly anticipated commercialization stage,” said Victor Rocha, Founder and CEO of Neurofarms, LLC. “Applying our line of CBD products to over a thousand patients, with virtually no side effects, highlights the potential of our portfolio to treat a range of medical conditions, supporting our position as one of the most successful and influential players in the emerging segment of the cannabis industry. As a result, we achieved critical mass and felt that the time was right to partner with GreenGro Technologies, a leader in the cannabis industry. industry with manufacturing and distribution expertise, to support our marketing plans.

“Securing this opportunity with Neurofarms marks a significant achievement for Cannabis Ventures, a wholly owned subsidiary of GreenGro Technologies, Inc.,” said Robert Martinez, President and CEO of Cannabis Ventures. “We anticipate that the revenues from our agreement with Neurofarms will allow us to achieve profitability by the next fiscal quarter ending March 31, 2022, a key step on GreenGro’s path to becoming a global leader in the development and commercialization of ancillary services for the cannabis market, ”concluded Mr. Martinez.

“We believe that the combined capabilities of GreenGro Technologies and Neurofarms will produce the highest quality products and optimum efficiency for our consumers,” said James Haas, President and COO of GreenGro Technologies, Inc. “Neurofarms has already made significant advancements in the medical field thanks to its unique ability to successfully treat a number of diseases through the use of healing properties derived from herbs, hemp and cannabinoids. The unique formulations of Neurofarms combined with GreenGro’s business infrastructure should ensure the successful launch of our new partnership, ”concluded Mr. Haas.

To be added to the Company’s mailing list, please click on this link or for more information, please call our public relations department at 323-380-4500.

About GreenGro Technologies, Inc.

GreenGro Technologies, Inc. (OTC Pink: GRNH) is a vertically integrated provider of cutting edge, environmentally friendly technology solutions for green industries. The Company is a trusted partner for the cultivation, extraction, production and retail aspects of the green market through a combination of three operating divisions: CBD Ventures, Cannabis Ventures and GenoBreeding. Each division is able to leverage the strengths of the other, creating a synergistic, efficient and highly profitable business model.

For more information on GreenGro Technologies and its solutions, please visit or the Company’s website at

(Safe Harbor Act: The company relies on the Safe Harbor Acts of 1933, 1934 and 1995 for all public press releases. Statements, which are not historical facts, are forward-looking statements. The company, by the ‘intermediary of its management, makes forward-looking statements public statements regarding its future operations, performance and other developments. These forward-looking statements are necessarily estimates reflecting the best judgment of the company based on current information and involve several risks and uncertainties, and There can be no assurance that other factors will not affect the accuracy of these forward-looking statements. It is impossible to identify all of these factors. Factors that could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and sustaining growth, eff and adverse publicity; litigation; competetion ; and other factors that may be identified from time to time in the business of your public announcements.)

Company details :

Darrel courtney
Chief Executive Officer
Telephone: 888-217-6058

Contact person for public relations:

GreenGro Public Relations
Telephone: 323-380-4500

Disclaimer / Disclosure: is a digital publisher of third party equity news, articles and research and creates original content including videos, interviews and articles. Original content created by Investorideas is protected by copyright laws other than syndication rights. Our site does not make any recommendations to buy or sell any stock, service or product. Nothing on our sites should be construed as an offer or a solicitation to buy or sell any products or securities. Any investment involves risks and possible losses. This site is currently paid for news publishing and distribution, social media and marketing, content creation and more. Disclosure is issued for every paid press release, content posted / created as necessary, but otherwise the news has not been paid and has been published for the sole benefit of our readers and subscribers. Contact the management and IR of each company directly for specific questions.

More information on the disclaimer: Learn more about posting your press release and our other news feed services press / and

Global investors must adhere to the regulations of each country. Please read the privacy policy:

Buy a guest article on cannabis at


Leave A Reply

Your email address will not be published.